211 related articles for article (PubMed ID: 12362226)
21. Exchange transfusion activates coagulation and alters the coagulation profile in newborn infants.
Långström S; Wartiovaara-Kautto U; Andersson S; Heikinheimo M; Petäjä J
Thromb Haemost; 2006 Aug; 96(2):142-8. PubMed ID: 16894456
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of factor IIa inhibitors on the endogenous thrombin potential.
Beilfuss A; Grandoch M; Wenzel F; Hohlfeld T; Schrör K; Weber AA
Ther Drug Monit; 2008 Dec; 30(6):740-3. PubMed ID: 18824953
[TBL] [Abstract][Full Text] [Related]
23. Thrombin generation determined by calibrated automated thrombography (CAT) in pediatric patients with congenital heart disease.
Koestenberger M; Cvirn G; Nagel B; Rosenkranz A; Leschnik B; Gamillscheg A; Beitzke A; Muntean W
Thromb Res; 2008; 122(1):13-9. PubMed ID: 17915295
[TBL] [Abstract][Full Text] [Related]
24. Proteins invoked by vitamin K absence and clotting times in clinically ill cats.
Center SA; Warner K; Corbett J; Randolph JF; Erb HN
J Vet Intern Med; 2000; 14(3):292-7. PubMed ID: 10830543
[TBL] [Abstract][Full Text] [Related]
25. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
26. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW; Kim HK; Kim JE; Park S; Cho HI
Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
[TBL] [Abstract][Full Text] [Related]
27. Thrombin generation, a function test of the haemostatic-thrombotic system.
Hemker HC; Al Dieri R; De Smedt E; Béguin S
Thromb Haemost; 2006 Nov; 96(5):553-61. PubMed ID: 17080210
[TBL] [Abstract][Full Text] [Related]
28. Thrombin generation assay as a possible tool for assessment of reduced activity of clotting factors induced by antiphospholipid antibodies and in-vitro evaluation of treatment options.
Livnat T; Zivelin A; Tamarin I; Guetta V; Salomon O
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):661-6. PubMed ID: 19730246
[TBL] [Abstract][Full Text] [Related]
29. Thrombin generation as an intermediate phenotype for venous thrombosis.
Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E
Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924
[TBL] [Abstract][Full Text] [Related]
30. Poor prognosis of hypocoagulability assessed by thrombin generation assay in disseminated intravascular coagulation.
Lee K; Kim JE; Kwon J; Kim I; Yoon SS; Park S; Han KS; Kim HK
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):241-7. PubMed ID: 24675694
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII.
Chaves DG; Fonseca FML; Araújo HCB; de Oliveira LMM; Amorim MVA; Assis Neto CC; Carvalho MDG
Blood Coagul Fibrinolysis; 2022 Dec; 33(8):463-467. PubMed ID: 36409923
[TBL] [Abstract][Full Text] [Related]
32. Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency.
Tran HT; Tjønnfjord GE; Holme PA
Haemophilia; 2014 Jan; 20(1):141-6. PubMed ID: 23992369
[TBL] [Abstract][Full Text] [Related]
33. Thrombin generation in platelet-rich plasma as a tool for the detection of hypercoagulability in young stroke patients.
Faber CG; Lodder J; Kessels F; Troost J
Pathophysiol Haemost Thromb; 2003; 33(1):52-8. PubMed ID: 12853713
[TBL] [Abstract][Full Text] [Related]
34. Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth?
Koutroumpi S; Spiezia L; Albiger N; Barbot M; Bon M; Maggiolo S; Gavasso S; Simioni P; Frigo A; Mantero F; Scaroni C
Pituitary; 2014 Feb; 17(1):68-75. PubMed ID: 23408210
[TBL] [Abstract][Full Text] [Related]
35. The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency.
Livnat T; Shenkman B; Martinowitz U; Zivelin A; Dardik R; Tamarin I; Mansharov R; Budnik I; Salomon O
Thromb Res; 2015 Aug; 136(2):465-73. PubMed ID: 26160656
[TBL] [Abstract][Full Text] [Related]
36. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?
Giansily-Blaizot M; Verdier R; Biron-Adréani C; Schved JF; Bertrand MA; Borg JY; Le Cam-Duchez V; Briquel ME; Chambost H; Pouymayou K; Dutrillaux F; Favier R; Martin-Toutain I; Verdy E; Gay V; Goudemand J; Navarro R; Durin A; d'Oiron R; Lambert T; Pernod G; Barrot C; Peynet J; Bastenaire B; Sie P; Stieltjes N; Torchet MF; de Moerloose P;
Haematologica; 2004 Jun; 89(6):704-9. PubMed ID: 15194538
[TBL] [Abstract][Full Text] [Related]
37. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
Girolami A; Scandellari R; Scapin M; Vettore S
Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
[TBL] [Abstract][Full Text] [Related]
38. "In vitro" correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate.
Bulato C; Novembrino C; Anzoletti MB; Spiezia L; Gavasso S; Berbenni C; Tagariello G; Farina C; Nardini I; Campello E; Peyvandi F; Simioni P
Haemophilia; 2018 Jul; 24(4):648-656. PubMed ID: 29578313
[TBL] [Abstract][Full Text] [Related]
39. Whole blood thrombin generation in Bmal1-deficient mice.
Ninivaggi M; Kelchtermans H; Kuijpers MJ; Hemmeryckx B; Heemskerk JW; Lindhout T; Hoylaerts MF; de Laat B
Thromb Haemost; 2014 Aug; 112(2):271-5. PubMed ID: 24740693
[TBL] [Abstract][Full Text] [Related]
40. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
